Načítá se...
Cardioprotective interventions for cancer patients receiving anthracyclines
BACKGROUND: Anthracyclines are among the most effective chemotherapeutic agents in the treatment of numerous malignancies. Unfortunately, their use is limited by a dose‐dependent cardiotoxicity. In an effort to prevent this cardiotoxicity, different cardioprotective agents have been studied. OBJECTI...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2011
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457676/ https://ncbi.nlm.nih.gov/pubmed/21678342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003917.pub4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|